FXYD domain containing ion transport regulator 6 pseudogene 3 (FXYD6P3)

FXYD6P3 (FXYD domain containing ion transport regulator 6 pseudogene 3), also known as Putative FXYD domain-containing ion transport regulator 8 or FXYD8, is classified as a pseudogene in humans. It is predicted to enable sodium channel regulator activity and be related to positive regulation of sodium ion export across the plasma membrane, but as a pseudogene, it does not produce a functional protein and is not considered a therapeutic target. The primary functional gene in this family is FXYD6, which is a protein-coding gene involved in sodium transport regulation, but FXYD6P3 itself lacks known biological or disease roles, established interacting drugs, or clinical relevance as a drug target. The primary source gene family (FXYD) codes for membrane-associated ion transport regulators, but "pseudogene" in the case of FXYD6P3 means it is not functionally/proteomically active and carries no current therapeutic or diagnostic significance. Pseudogenes are sometimes transcribed, but no evidence demonstrates that FXYD6P3 has a clinical or biochemical role in humans. There is risk of confusion with the functional gene FXYD6, which is an actual member of the FXYD family and can be a research biomarker, but this does not apply to FXYD6P3. FXYD6P3 is not listed as interacting with drugs, nor is it used as a biomarker or therapeutic target in published resources.

Other names

FXYD6P3Putative FXYD domain-containing ion transport regulator 8FXYD8